Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008

200720062004

2007 Archives

Dec 12, 2007
Company to Launch Product Immediately

Philadelphia, PA – December 12, 2007 – Lannett Company, Inc. (Amex: LCI) today announced it has received approval from the U.S. Food and Drug Administration (FDA) for the company’s...

More
Nov 12, 2007

Philadelphia, PA – August 1, 2008 – Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, today announced that it has received approvals from the U.S. Food and...

More
Nov 12, 2007

Philadelphia, PA – May 15, 2008 – Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, said today that it continues to work closely with the U.S. Food and Drug...

More
May 8, 2007

Lannett Company, Inc. (Amex: LCI) today announced that Larry Dalesandro, its Chief Financial Officer (CFO), has resigned effective December 1, 2004 for personal reasons. Lannett has appointed...

More
Apr 23, 2007

Philadelphia, PA – June 2, 2010 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that Arthur Bedrosian, president and chief executive officer, will present a company overview...

More
Feb 8, 2007

PHILADELPHIA, PA – November 16, 2004 – LANNETT ® COMPANY, INC. (AMEX: LCInews), a manufacturer of generic pharmaceuticals, is pleased to announce the launch of three new drug...

More
 

print email rss
Lannett Investor Relations
Lannett Company Products